Hypoxanthine

Hypoxanthine

SCHEMBL4456030

O=c1[nH]cnc2nc[nH]c12.c1ncc2nc[nH]c2n1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
KDM4A O75164 1/20 0.42
KDM4B O94953 1/20 0.42
KDM5C P41229 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
KDM5B Q9UGL1 1/20 0.42
KDM3A Q9Y4C1 1/20 0.42
PNP P00491 1/20 0.42
PI4KA P42356 2/20 0.40
PI4K2B Q8TCG2 2/20 0.40
PI4K2A Q9BTU6 2/20 0.40
PI4KB Q9UBF8 2/20 0.40
LMNA P02545 2/20 0.40
XDH P47989 2/20 0.40
DRD3 P35462 1/20 0.40
LRRK2 Q5S007 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.38
TSHR P16473 1/20 0.38
ADORA2A P29274 1/20 0.38
SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Purine SCHEMBL29456595 0.82
Purine SCHEMBL2120547 0.82 KDM4A (0.38) ALDH1A1KDM4AKDM4BKDM5CKDM4C
Purine SCHEMBL6421376 0.82 KDM4A (0.38) ALDH1A1KDM4AKDM4BKDM5CKDM4C
Purine SCHEMBL3157 0.82
Purine SCHEMBL1389668 0.80 KDM4A (0.37) ALDH1A1KDM4AKDM4BKDM5CKDM4C
Purine SCHEMBL7787135 0.80 KDM4A (0.37) ALDH1A1KDM4AKDM4BKDM5CKDM4C
Purine SCHEMBL5578775 0.80 KDM4A (0.37) ALDH1A1KDM4AKDM4BKDM5CKDM4C
Purine SCHEMBL37119 0.80 KDM4A (0.37) ALDH1A1KDM4AKDM4BKDM5CKDM4C
Purine SCHEMBL9057416 0.80 KDM4A (0.37) ALDH1A1KDM4AKDM4BKDM5CKDM4C
Purine SCHEMBL6438162 0.80 KDM4A (0.37) ALDH1A1KDM4AKDM4BKDM5CKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090226439-A1 METHOD FOR TREATING DEMENTIA OR ALZHEIMER'S DISEASE GENENTECH, INC. (US) 2009-09-10 US claimed
CN-101203242-A Methods of treating dementia or Alzheimer's disease with CD20 antibodies GENENTECH INC (US) 2008-06-18 CN claimed
EP-1874350-A2 METHOD FOR TREATING DEMENTIA OR ALZHEIMER'S DISEASE WITH A CD20 ANTIBODY Genentech, Inc. (US) 2008-01-09 EP claimed
WO-2006116369-A2 METHOD FOR TREATING DEMENTIA OR ALZHEIMER'S DISEASE WITH A CD20 ANTIBODY GENENTECH, INC. (US) 2006-11-02 WO claimed
US-20060240007-A1 Method for treating dementia or Alzheimer's disease GENENTECH, INC. 2006-10-26 US claimed
EP-4351661-A1 RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR LESCH-NYHAN DISORDERS AND USES THEREOF The Trustees of The University of Pennsylvania (US) 2024-04-17 EP disclosed
WO-2022261187-A1 RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR LESCH-NYHAN DISORDERS AND USES THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2022-12-15 WO disclosed
US-20220133818-A1 METHOD AND COMPOSITION FOR TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2022-05-05 US disclosed
EP-3930735-A1 METHOD AND COMPOSITION FOR TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS The Regents of the University of Colorado, a body corporate (US) 2022-01-05 EP disclosed
CN-109072237-A Compositions and methods for reducing expression of TAU 诺华股份有限公司 2018-12-21 CN disclosed
EP-3259588-A1 HIGH SENSITIVITY METHOD FOR EARLY LYME DISEASE DETECTION Colorado State University Research Foundation (US) 2017-12-27 EP disclosed
EP-3215633-A1 SYSTEM, METHOD AND APPARATUS FOR DETERMINING THE EFFECT OF GENETIC VARIANTS Metabolon, Inc. (US) 2017-09-13 EP disclosed
US-5750729-A REACTING PROTECTED PYRAN DERIVATIVES TO FORM NUCLEOTIDES GILEAD SCIENCES,INC. (US) 1998-05-12 US disclosed
US-5693771-A REACTING PROTECTED PYRAN COMPOUND WITH PHOSPHITE AND HETEROCYCLIC BASE GILEAD SCIENCES, INC. (US) 1997-12-02 US disclosed
EP-0807118-A2 NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME GILEAD SCIENCES, INC. (US) 1997-11-19 EP disclosed
US-5659023-A HETEROCYCLIC FURANOSYL OR PYRANOSYL PHOSPHONATE; IMMUNOGENS, OLIGONUCLEOTIDES, ANTIINFECTIVES, ANTIINFLAMMATORY AGENTS GILEAD SCIENCES, INC. (US) 1997-08-19 US disclosed
EP-0772440-A1 CARBON MONOXIDE DEPENDENT GUANYLYL CYCLASE MODIFIERS GLASKY, Alvin J. (US) 1997-05-14 EP disclosed
WO-1996023801-A2 NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME GILEAD SCIENCES, INC. (US) 1996-08-08 WO disclosed
WO-1996003125-A1 CARBON MONOXIDE DEPENDENT GUANYLYL CYCLASE MODIFIERS GLASKY ALVIN J (US) 1996-02-08 WO disclosed
US-5447939-A Purine derivatives used for long term modification of neural activity in mammals, for treatment of mammalian neurological diseases, and for inducing long term changes in membrane potential of mammalian neuron SPECTRUM PHARMACEUTICALS, INC. 1995-09-05 US disclosed